Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype

被引:28
|
作者
Su, Linjuan [1 ]
Huang, Hailong [1 ]
An, Gang [1 ]
Cai, Meiying [1 ]
Wu, Xiaoqing [1 ]
Li, Ying [1 ]
Xie, Xiaorui [1 ]
Lin, Yuan [1 ]
Wang, Meiying [1 ]
Xu, Liangpu [1 ]
机构
[1] Fujian Med Univ, Fujian Prov Matern & Childrens Hosp, Fujian Prov Key Lab Prenatal Diag & Birth Defect, Affiliated Hosp, Fuzhou, Fujian, Peoples R China
来源
关键词
chromosomal microarray analysis; karyotyping; nuchal translucency; prenatal diagnosis; GENOMIC MICROARRAY; THICKNESS; MOSAICISM; DELETIONS; 22Q11.2;
D O I
10.1002/mgg3.811
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Submicroscopic chromosomal imbalance is associated with an increased nuchal translucency (NT). Most previous research has recommended the use of chromosomal microarray analysis (CMA) for prenatal diagnosis if the NT >= 3.5 mm. However, there is no current global consensus on the cutoff value for CMA. In this study, we aimed to discuss the fetuses with smaller increased NT which was between cutoff value of NT for karyotype analysis (NT of 2.5 mm in China) and the recommended cutoff value for CMA (NT of 3.5 mm) whether should be excluded from CMA test. Methods Singleton pregnant women (N = 192) who had undergone invasive procedures owing to an increased NT (NT >= 2.5 mm) were enrolled. Fetal cells were collected and subjected to single nucleotide polymorphism array and karyotype analyses simultaneously. Cases were excluded if the karyotype analysis indicated aneuploidy and apparent structural aberrations. Results Fourteen cases of aneuploidy and four cases of structural abnormalities were excluded. Of the remaining 174 cases, 119 fetuses had NTs of 2.5-3.4 mm, and 55 fetuses with NT >= 3.5 mm. Eleven copy number variants (CNVs) were identified. In fetuses with smaller NTs, six (6/119, 5.9%) variations were detected, including two (2/119, 1.6%) clinically significant CNVs (pathogenic or likely pathogenic CNV), one likely benign CNV, two variants unknown significance, and one incidental CNV. Five (5/55, 9.1%) variations were found in fetuses with NT >= 3.5 mm. Among these CNVs, three (3/55, 5.5%) cases had clinically significant CNVs, and two had likely benign CNV. There were no statistically significant differences in the incidence of all CNVs and clinically significant CNVs in the two groups (p > 0.05). Conclusion CMA improved the diagnostic yield of chromosomal aberrations for fetuses with NTs of 2.5-3.4 mm and apparently normal karyotype, regardless of whether other ultrasonic abnormalities were observed.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Increased nuchal translucency, normal karyotype and infant development
    Miltoft, C. B.
    Ekelund, C. K.
    Hansen, B. M.
    Lando, A.
    Petersen, O. B.
    Skovbo, P.
    Jorgensen, F. S.
    Sperling, L.
    Zingenberg, H.
    Nikkila, A.
    Shalmi, A. C.
    Stornes, I.
    Ersbak, V.
    Tabor, A.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2012, 39 (01) : 28 - 33
  • [32] Increased nuchal translucency and normal karyotype: coping with uncertainty
    Bilardo, CM
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2001, 17 (02) : 99 - 101
  • [33] CHROMOSOMAL DEFECTS AND OUTCOME IN 1015 FETUSES WITH INCREASED NUCHAL TRANSLUCENCY
    PANDYA, PP
    KONDYLIOS, A
    HILBERT, L
    SNIJDERS, RJM
    NICOLAIDES, KH
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1995, 5 (01) : 15 - 19
  • [34] Outcome of fetuses with increased nuchal translucency and normal karyotypes
    Winsor, S
    Conacher, S
    Chitayat, D
    Johnson, J
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 185 (06) : S249 - S249
  • [35] Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency
    Sinajon, P.
    Chitayat, D.
    Roifman, M.
    Wasim, S.
    Carmona, S.
    Ryan, G.
    Noor, A.
    Kolomietz, E.
    Chong, K.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2020, 55 (03) : 383 - 390
  • [36] Targeted ultrasound examination and DNA testing for Noonan syndrome, in fetuses with increased nuchal translucency and normal karyotype
    Bakker, M.
    Pajkrt, E.
    Mathijssen, I. B.
    Bilardo, C. M.
    [J]. PRENATAL DIAGNOSIS, 2011, 31 (09) : 833 - 840
  • [37] Genetic assessment following increased nuchal translucency and normal karyotype
    Pergament, Eugene
    Alamillo, Christina
    Sak, Katrin
    Fiddler, Morris
    [J]. PRENATAL DIAGNOSIS, 2011, 31 (03) : 307 - 310
  • [38] CGH analysis in a cohort of 17 chromosomally normal fetuses with an increased nuchal translucency
    Brisset, S
    Romana, S
    Texier, I
    Lapierre, JM
    North, MO
    Vekemansand, M
    Morichon-Delvallez, N
    [J]. PRENATAL DIAGNOSIS, 2003, 23 (12) : 1017 - 1018
  • [39] Increased nuchal translucency and normal karyotype: value of additional testing
    Lucas, Jaclyn Coletta
    Dugan, Elizabeth Kramer
    Aggarwal, Vimla
    Bale, Sherri
    Frayna, Aileen
    Hussong, Melanie
    Jobanputra, Vaidehi
    Richard, Gabi
    Vincent, Lisa
    Williams, Bradley
    Meck, Jeanne
    Wapner, Ronald
    Levy, Brynn
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 210 (01) : S87 - S87
  • [40] Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency
    Lehner, C.
    Singh, R.
    Chenoweth, K.
    McGrath, P.
    Portmann, C.
    Sekar, R.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 : 54 - 54